Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • PharmaData

    PharmaData are award-winning specialists in pharmaceutical data analytics driving strategy, engaging teams and measuring change across Australia and Europe. Our proprietary products help our clients identify and act on opportunities to; increase generic substitution, improve efficiency, engage sales forces, drive strategy, build ‘sticky’ business relationships, achieve greater depth in market, encourage customer loyalty and help deliver more patient centric care.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    Genetic Digital

    We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

    View Profile

    Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

    Nmblr

    From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

    View Profile

    IT solutions

    Company Details

    PharmaData
    The Limestore, Level 1 33 Longland Street, Newstead, Queensland, 4006, Australia
    +617 3171 9900
    Contact PharmaData
    Website

     Latest Content from PMHub 

    The Mission to Humanize Healthcare

    Press Releases | August 7, 2025 | Medscape Education

    Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital element of progressive healthcare – patient integration.

    Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process

    White Papers and Resources | August 6, 2025 | Petauri Evidence

    Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health technology assessment (HTA)...

    Designing with patients in mind: How to build more inclusive clinical trials

    Press Releases | August 4, 2025 | Cuttsy + Cuttsy

    Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

    Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

    White Papers and Resources | August 1, 2025 | Innovative Trials

    Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

    The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

    White Papers and Resources | August 1, 2025 | Innovative Trials

    Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

    Three Key Trends Shaping the Future of Clinical Trials

    White Papers and Resources | August 1, 2025 | Innovative Trials

    So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

    Advertising For Women’s Health: Breaking Taboos and Driving Change

    White Papers and Resources | July 30, 2025 | 11 London

    Our strategist Stephanie Goley, MSc, PhD takes a fascinating look at how advertising is breaking down stigmas around areas of women's health such as menstruation and menopause - and helping...

    Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

    Press Releases | July 30, 2025 | Genesis Research Group

    HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

    Digital Transformation in the NHS’s 10-Year Plan: Techno-Optimism and the Limits of Efficiency

    White Papers and Resources | July 29, 2025 | Petauri Evidence

    Here, Evelyne Priestman (Senior Consultant – HEOR) and Mary Baker (Senior Medical Writer) at Petauri Evidence explore the National Health Service (NHS) in England’s newly unveiled 10-year plan through the...

    Bridging the gap: Should pharma step up as public health campaign funding declines?

    White Papers and Resources | July 28, 2025 | Say Communications

    With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the pharmaceutical industry to step forward and do more to support the nation’s...